{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:39:35Z","timestamp":1779237575493,"version":"3.51.4"},"reference-count":99,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL130996"],"award-info":[{"award-number":["R01HL130996"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2018.06.004","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T23:24:46Z","timestamp":1533079486000},"page":"2897-2904","source":"Crossref","is-referenced-by-count":7,"title":["The Genetic Landscape of Cerebral Steno-Occlusive Arteriopathy and Stroke in Sickle Cell Anemia"],"prefix":"10.1016","volume":"27","author":[{"given":"Catherine","family":"Amlie-Lefond","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Kanter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William B.","family":"Dobyns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0001","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ajh.21570","article-title":"The number of people with sickle-cell disease in the United States: national and state estimates","volume":"85","author":"Brousseau","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0002","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0003","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001484","article-title":"Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions","volume":"10","author":"Piel","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0005","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1212\/WNL.0000000000004537","article-title":"Neurologic complications of sickle cell disease in Africa: a systematic review and meta-analysis","volume":"89","author":"Noubiap","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0006","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/08830738050200020301","article-title":"Cognitive deficits in children with sickle cell disease","volume":"20","author":"Steen","year":"2005","journal-title":"J Child Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0007","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1001\/jama.2010.562","article-title":"Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia","volume":"303","author":"Vichinsky","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0008","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.3324\/haematol.2017.169581","article-title":"Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases","volume":"102","author":"Arnold","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0009","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/17474086.2018.1407240","article-title":"Sickle cell disease: a malady beyond a hemoglobin defect in cerebrovascular disease","volume":"11","author":"Ansari","year":"2018","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0010","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene-Frempong","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0011","series-title":"Sickle cell disease: scientific principles and clinical practice","first-page":"599","article-title":"Neurologic complications","author":"Adams","year":"1994"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0012","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0002-9343(78)90772-6","article-title":"The natural history of stroke in sickle cell disease","volume":"65","author":"Powars","year":"1978","journal-title":"Am J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0013","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1182\/blood.V63.1.162.162","article-title":"Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease","volume":"63","author":"Russell","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0014","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ajh.23625","article-title":"Sickle-cell disease stroke throughout life: a retrospective study in an adult referral center","volume":"89","author":"Gueguen","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0015","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ana.10727","article-title":"Brain injury in children with sickle cell disease: prevalence and etiology","volume":"54","author":"Steen","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0016","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3171\/2011.12.PEDS1172","article-title":"Spontaneous occlusion of the circle of Willis in children: pediatric moyamoya summary with proposed evidence-based practice guidelines. A review","volume":"9","author":"Smith","year":"2012","journal-title":"J Neurosurg Pediatr"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0017","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood-2013-12-545186","article-title":"Magnetic resonance imaging\/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial","volume":"124","author":"Helton","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0018","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bcmd.2014.08.007","article-title":"Cerebral vasculopathy in children with sickle cell anemia","volume":"54","author":"Fasano","year":"2015","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0019","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1148\/radiol.2281020943","article-title":"Brain imaging findings in pediatric patients with sickle cell disease","volume":"228","author":"Steen","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0020","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3324\/haematol.2010.022624","article-title":"Extracranial internal carotid arterial disease in children with sickle cell anemia","volume":"95","author":"Deane","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0021","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3171\/2013.10.FOCUS13405","article-title":"Pial synangiosis for moyamoya syndrome in children with sickle cell anemia: a comprehensive review of reported cases","volume":"36","author":"Kennedy","year":"2014","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0022","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1182\/blood-2011-03-337915","article-title":"Cervical carotid artery disease in sickle cell anemia: clinical and radiological features","volume":"118","author":"Telfer","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0023","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1182\/blood-2010-01-261123","article-title":"Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease","volume":"117","author":"Hulbert","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0024","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1182\/blood.V99.9.3144","article-title":"Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events","volume":"99","author":"Dobson","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0025","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3171\/2017.1.PEDS16576","article-title":"Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome","volume":"20","author":"Yang","year":"2017","journal-title":"J Neurosurg Pediatr"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0026","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3171\/PED\/2008\/1\/3\/211","article-title":"Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis","volume":"1","author":"Hankinson","year":"2008","journal-title":"J Neurosurg Pediatr"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0027","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.3171\/2009.01.FOCUS08307","article-title":"Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome","volume":"26","author":"Smith","year":"2009","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0028","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0887-8994(96)00045-8","article-title":"Encephaloduroarterio-synangiosis in a child with sickle cell anemia and moyamoya disease","volume":"14","author":"Vernet","year":"1996","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0029","first-page":"142","article-title":"Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis","volume":"100","author":"Scott","year":"2004","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0030","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/pbc.26022","article-title":"Reduction in overt and silent stroke recurrence rate following cerebral revascularization surgery in children with sickle cell disease and severe cerebral vasculopathy","volume":"63","author":"Hall","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0031","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199202273260905","article-title":"The use of transcranial ultrasonography to predict stroke in sickle cell disease","volume":"326","author":"Adams","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0032","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0033","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ana.410420505","article-title":"Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler","volume":"42","author":"Adams","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0034","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/pbc.24240","article-title":"Adherence to transcranial Doppler screening guidelines among children with sickle cell disease","volume":"60","author":"Eckrich","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0035","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1182\/blood-2003-06-1972","article-title":"Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study","volume":"103","author":"Abboud","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0036","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1056\/NEJMoa050460","article-title":"Optimizing primary stroke prevention in sickle cell anemia trial I. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease","volume":"353","author":"Adams","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0037","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(15)01041-7","article-title":"Hydroxycarbamide versus chronic transfusion for maintenance of transcranial Doppler flow velocities in children with sickle cell anaemia-TCD with transfusions changing to hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial","volume":"387","author":"Ware","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0038","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/01.STR.23.8.1073","article-title":"Transcranial Doppler correlation with cerebral angiography in sickle cell disease","volume":"23","author":"Adams","year":"1992","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0039","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/BF02012192","article-title":"Correlation of transcranial Doppler ultrasonography with MRI and MRA in the evaluation of sickle cell disease patients with prior stroke","volume":"24","author":"Kogutt","year":"1994","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0040","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/pbc.24569","article-title":"Transcranial Doppler velocity and brain MRI\/MRA changes in children with sickle cell anemia on chronic transfusions to prevent primary stroke","volume":"60","author":"Sheehan","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0041","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/bjh.12034","article-title":"Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemia","volume":"159","author":"Thangarajh","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0042","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1182\/blood-2003-08-2733","article-title":"Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study","volume":"103","author":"Adams","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0043","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood-2010-06-293514","article-title":"Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort","volume":"117","author":"Bernaudin","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0044","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1182\/blood-2015-10-675231","article-title":"Long-term treatment follow-up of children with sickle cell disease monitored with abnormal transcranial Doppler velocities","volume":"127","author":"Bernaudin","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0045","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1182\/blood-2005-10-009506","article-title":"Stroke prevention trial in sickle cell anemia (STOP): extended follow-up and final results","volume":"108","author":"Lee","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0046","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5581\/1516-8484.20120078","article-title":"Abnormal transcranial Doppler ultrasonography in children with sickle cell disease","volume":"34","author":"Leite","year":"2012","journal-title":"Rev Bras Hematol Hemoter"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0047","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00247-005-1419-5","article-title":"Long-term follow-up of pediatric sickle cell disease patients with abnormal high velocities on transcranial Doppler","volume":"35","author":"Bernaudin","year":"2005","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0048","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bcmd.2011.06.002","article-title":"Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia","volume":"47","author":"Bishop","year":"2011","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0049","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00277-008-0670-x","article-title":"Does regular blood transfusion prevent progression of cerebrovascular lesions in children with sickle cell disease","volume":"88","author":"Brousse","year":"2009","journal-title":"Ann Hematol."},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0050","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1067\/mpd.2002.122498","article-title":"Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke","volume":"140","author":"Scothorn","year":"2002","journal-title":"J Pediatr"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0051","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ajh.21476","article-title":"The excess burden of stroke in hospitalized adults with sickle cell disease","volume":"84","author":"Strouse","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0052","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/mic.11.2.129.151","article-title":"The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy","volume":"11","author":"Hebbel","year":"2004","journal-title":"Microcirculation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0053","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1182\/blood-2013-05-498311","article-title":"Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies","volume":"122","author":"Manwani","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0054","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399406010659","article-title":"Pathophysiology and therapy for haemoglobinopathies. Part I: sickle cell disease","volume":"8","author":"Madigan","year":"2006","journal-title":"Expert Rev Mol Med."},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0055","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ajh.21475","article-title":"Vasculopathy in sickle cell disease: biology, pathophysiology, genetics, translational medicine, and new research directions","volume":"84","author":"Kato","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bcr-2014-205464","article-title":"Subarachnoid haemorrhage and cerebral vasculopathy in a child with sickle cell anaemia","volume":"2014","author":"Inusa","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0057","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/01.STR.9.1.45","article-title":"Cerebrovascular disease in sickle cell anemia: a clinical, pathological and radiological correlation","volume":"9","author":"Merkel","year":"1978","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0058","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ajh.21558","article-title":"Proinflammatory phenotype with imbalance of KLF2 and RelA: risk of childhood stroke with sickle cell anemia","volume":"85","author":"Enenstein","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0059","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2141.2006.06103.x","article-title":"Serum levels of angiogenic factors indicate a pro-angiogenic state in adults with sickle cell disease","volume":"134","author":"Duits","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0060","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/87904","article-title":"Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions","volume":"7","author":"Carmeliet","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0061","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1182\/blood.V101.6.2401","article-title":"Stroke risk in siblings with sickle cell anemia","volume":"101","author":"Driscoll","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0062","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1046\/j.1365-2141.2003.04276.x","article-title":"Transcranial Doppler ultrasonography in siblings with sickle cell disease","volume":"121","author":"Kwiatkowski","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0063","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/ng1533","article-title":"Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia","volume":"37","author":"Sebastiani","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0064","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ajh.21572","article-title":"Genetic modifiers of the severity of sickle cell anemia identified through a genome-wide association study","volume":"85","author":"Sebastiani","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0065","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1182\/blood-2011-01-332205","article-title":"Genetic predictors for stroke in children with sickle cell anemia","volume":"117","author":"Flanagan","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0066","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/bjh.12791","article-title":"Haptoglobin, alpha-thalassaemia and glucose-6-phosphate dehydrogenase polymorphisms and risk of abnormal transcranial Doppler among patients with sickle cell anaemia in Tanzania","volume":"165","author":"Cox","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0067","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bcmd.2014.08.001","article-title":"Association of alpha-thalassemia, TNF-alpha (-308G>A) and VCAM-1 (c.1238G>C) gene polymorphisms with cerebrovascular disease in a newborn cohort of 411 children with sickle cell anemia","volume":"54","author":"Belisario","year":"2015","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0068","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jped.2016.01.010","article-title":"Genetic determinants and stroke in children with sickle cell disease","volume":"92","author":"Rodrigues","year":"2016","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0069","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1182\/blood-2015-05-645176","article-title":"Association between ENPP1 K173Q and stroke in a newborn cohort of 395 Brazilian children with sickle cell anemia","volume":"126","author":"Belisario","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0070","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2003-09-3015","article-title":"Gene interactions and stroke risk in children with sickle cell anemia","volume":"103","author":"Hoppe","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0071","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1161\/STROKEAHA.107.483115","article-title":"Confirmation of an association between the TNF(-308) promoter polymorphism and stroke risk in children with sickle cell anemia","volume":"38","author":"Hoppe","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0072","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1182\/blood-2001-12-0306","article-title":"Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease","volume":"100","author":"Taylor","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0073","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1182\/blood-2012-10-464156","article-title":"Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia","volume":"121","author":"Flanagan","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0074","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/jama.1961.73040380028011b","article-title":"Amelioration of sickle cell disease by persistent fetal hemoglobin","volume":"177","author":"Jackson","year":"1961","journal-title":"JAMA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0075","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ajmg.1320270305","article-title":"The relationship between fetal hemoglobin and disease severity in children with sickle cell anemia","volume":"27","author":"Odenheimer","year":"1987","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0076","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1172\/JCI111464","article-title":"Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia","volume":"74","author":"Platt","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0077","first-page":"487","article-title":"Fetal hemoglobin concentration predicts disease severity in children with sickle cell anemia","volume":"251","author":"Rucknagel","year":"1987","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0078","series-title":"Disorders of hemoglobin: genetics, pathophysiology, and clinical management","author":"Steinberg","year":"2009"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0079","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-3476(81)80529-X","article-title":"Fetal hemoglobin and clinical severity of homozygous sickle cell disease in early childhood","volume":"98","author":"Stevens","year":"1981","journal-title":"J Pediatr"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0080","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1182\/blood-2012-06-432849","article-title":"Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans","volume":"120","author":"Bae","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0081","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1466-9218.2000.00001.x","article-title":"A candidate gene study of F cell levels in sibling pairs using a joint linkage and association analysis","volume":"1","author":"Garner","year":"2000","journal-title":"GeneScreen"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0082","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1073\/pnas.82.7.2111","article-title":"Common haplotype dependency of high G gamma-globin gene expression and high Hb F levels in beta-thalassemia and sickle cell anemia patients","volume":"82","author":"Labie","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0083","doi-asserted-by":"crossref","first-page":"11869","DOI":"10.1073\/pnas.0804799105","article-title":"DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease","volume":"105","author":"Lettre","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0084","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1177\/1535370216642047","article-title":"Original research: a case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease","volume":"241","author":"Liu","year":"2016","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0085","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1182\/blood-2007-05-093419","article-title":"The HBS1L-MYB intergenic region on chromosome 6q23.3 influences erythrocyte, platelet, and monocyte counts in humans","volume":"110","author":"Menzel","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0086","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1172\/JCI71520","article-title":"HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers","volume":"124","author":"Stadhouders","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0087","doi-asserted-by":"crossref","first-page":"11346","DOI":"10.1073\/pnas.0611393104","article-title":"Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults","volume":"104","author":"Thein","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0088","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/ng2108","article-title":"A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15","volume":"39","author":"Menzel","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0089","doi-asserted-by":"crossref","first-page":"13191","DOI":"10.1038\/srep13191","article-title":"Moyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cells","volume":"5","author":"Ohkubo","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0090","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/ejhg.2017.92","article-title":"Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians","volume":"25","author":"Guey","year":"2017","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0091","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1161\/STROKEAHA.114.006244","article-title":"RNF213 rare variants in an ethnically diverse population with Moyamoya disease","volume":"45","author":"Cecchi","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0092","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.ajhg.2016.09.001","article-title":"RNF213 is associated with intracranial aneurysms in the French-Canadian population","volume":"99","author":"Zhou","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0093","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1097\/HJH.0000000000000625","article-title":"Exome sequencing in seven families and gene-based association studies indicate genetic heterogeneity and suggest possible candidates for fibromuscular dysplasia","volume":"33","author":"Kiando","year":"2015","journal-title":"J Hypertens"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0094","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1182\/blood-2016-09-702324","article-title":"Sickle cell anemia in sub-Saharan Africa: advancing the clinical paradigm through partnerships and research","volume":"129","author":"McGann","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0095","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bcmd.2017.08.010","article-title":"The pressing need for point-of-care diagnostics for sickle cell disease: A review of current and future technologies","volume":"67","author":"McGann","year":"2017","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0096","article-title":"Exome sequencing of phenotypic extremes identifies CAV2 and TMC6 as interacting modifiers of chronic Pseudomonas aeruginosa infection in cystic fibrosis","volume":"11","author":"Emond","year":"2015","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0097","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nature07811","article-title":"Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease","volume":"458","author":"Gu","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0098","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/ng.2344","article-title":"Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis","volume":"44","author":"Emond","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.004_bib0099","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/hep.27711","article-title":"Exome sequencing in HFE C282Y homozygous men with extreme phenotypes identifies a GNPAT variant associated with severe iron overload","volume":"62","author":"McLaren","year":"2015","journal-title":"Hepatology"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305718303197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305718303197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T20:59:50Z","timestamp":1720472390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305718303197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":99,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1052305718303197"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.06.004","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}